Western blot analysis of extracts from various cell lines using ELAVL1/HuR (D9W7E) Rabbit mAb.
Western blot analysis of extracts from 293 cells, mock transfected (-) or transfected with a construct expressing Myc/DDK-tagged full-length human ELAVL1/HuR (hELAVL1/HuR-Myc/DDK; +), using ELAVL1/HuR (D9W7E) Rabbit mAb (upper), DYKDDDDK Tag (9A3) Mouse mAb #8146 (middle), or β-Actin (D6A8) Rabbit mAb #8457 (lower).
Immunoprecipitation of ELAVL1/HuR from 293 cell extracts using Rabbit (DA1E) mAb IgG XP ® Isotype Control #3900 (lane 2) or ELAVL1/HuR (D9W7E) Rabbit mAb (lane 3). Lane 1 is 10% input. Western blot analysis was performed using ELAVL1/HuR (D9W7E) Rabbit mAb.
Confocal immunofluorescent analysis of NIH/3T3 cells, untreated (left) or actinomycin D-treated (5 μg/ml, 2 hr; right) using ELAVL1/HuR (D9W7E) Rabbit mAb (green). Actin filaments were labeled with DY-554 phalloidin (red).
Flow cytometric analysis of HEK-293 cells (green) using ELAVL1/HuR (D9W7E) Rabbit mAb (solid line) compared to concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed line). Anti-rabbit IgG (H+L), F(ab') 2 Fragment (Alex Fluor® 488 Conjugate) #4412 was used as a secondary antibody.